Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screening

Parkin, 1999, Global cancer statistics, CA Cancer J Clin, 49, 33, 10.3322/canjclin.49.1.33 Jemal, 2008, Cancer statistics, 2008, CA Cancer J Clin, 58, 71, 10.3322/CA.2007.0010 Ohno, 2004, Prediction of the future incidence of cancer in Japan, 201 Kuroishi, 2004, Prediction of the future mortality of cancer in Japan, 219 Sobue, 2008, Current activities and future directions of the cancer registration system in Japan, Int J Clin Oncol, 13, 97, 10.1007/s10147-008-0761-7 Kobori, 2008, Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1-10.0 ng/ml as a criterion, Int J Clin Oncol, 13, 229, 10.1007/s10147-007-0742-2 International Union Against Cancer, 1997, Urologic tumors: prostate, 170 Andriole, 2009, Mortality results from a randomized prostate-cancer screening trial, N Engl J Med, 360, 1310, 10.1056/NEJMoa0810696 Schroder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084 Bartsch, 2008, Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality, BJU Int, 101, 809, 10.1111/j.1464-410X.2008.07502.x Bouchardy, 2008, Recent trends in prostate cancer mortality show a continuous decrease in several countries, Int J Cancer, 123, 421, 10.1002/ijc.23520